On the other hand, a previous research demonstrated a higher prevalence of BRCA2 mutations compared to BRCA1 in other cancer types, including populations at increased risk for hereditary breast and ovarian cancer [31–33]. This evidence concerns the gene BRCA2 and ovarian cancer.